Evidence map›Paper›PMID 28508747›Full record

ArticleeLife2017

Voltage-gated Na

Xiulin Zhang, Birgit T Priest, Inna Belfer, Michael S Gold

Open access · goldAbstract readComparative Study
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 108 citations in OpenAlex.

  1. A neurocutaneous NaScience advances · 2026
    Article
  2. Targeting Supramolecular Active Complexes of NaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Human Dorsal Root Ganglia Neuronal Cell Line to Study Nociceptive Signaling: A New Pipeline for Pain Therapy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Modulation of human dorsal root ganglion neuron firing by the Nav1.8 inhibitor suzetrigine.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Xiulin ZhangDepartment of Urology, The Second Hospital of Shandong University, Jinan Shi, China.
Birgit T PriestLilly Research Laboratories, Indianapolis, United States.
Inna BelferOffice of Research on Women's Health, National Institutes of Health, Bethesda, United States.
Michael S GoldDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, United States.ORCID 0000-0002-2083-6206
Eli Lilly (United States) · USNational Institutes of Health · USSecond Hospital of Shandong University · CNUniversity of Pittsburgh · US

Funding

Mechanisms and Treatment of Dental PainR01DE018252 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOLD, MICHAEL S · 2009 to 2013
$2.4M
NIDCR NIH HHS R01 DE018252
6 · The paper itself

Abstract

Available evidence indicates voltage-gated Na

Indexed as

AnimalsCationsGanglia, SpinalHumansNeuronsPatch-Clamp TechniquesRatsSodiumVoltage-Gated Sodium ChannelsCationsSodiumVoltage-Gated Sodium Channelscell culturehumanlocal anestheticsNaV1.7NaV1.8neuroscience

Identifiers

PMID28508747
PMCPMC5433841
OpenAlexW2615918897

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.